An interventional study of Physical activity in Lacunar Stroke and Small Vessel Cerebrovascular Disease, sponsored by University of L'Aquila. Recruiting at 1 site in Italy. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-12-02.
Sponsored by University of L'Aquila · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The TELECONNECT-SVD study is a prospective, randomized, multicenter trial aimed at testing the efficacy of a remotely delivered exercise protocol on brain functional connectivity in patients with small vessel disease (SVD)-related ischemic stroke. The study will recruit patients aged ≥60 with a history of lacunar stroke, minimal disability (modified Rankin Scale score 0-1), and low physical activity levels.
The trial will include 60 participants randomized 1:1 to either a 24-week telecoached exercise intervention or usual care. The exercise program consists of multicomponent physical exercises delivered remotely twice a week. Assessments will be conducted at baseline, 12 weeks, 24 weeks, and 48 weeks.
Primary outcomes include changes in brain functional connectivity assessed by high-density EEG and improvements in physical fitness measured by the Senior Fitness Test. Secondary outcomes encompass changes in physical activity levels, anthropometric measurements, and vital signs.
The study employs a "wait list" design, where the control group receives the intervention after the initial 24-week period. This approach allows for assessment of the intervention's immediate effects and the retention of benefits after cessation.
Key features of the protocol include:
The study aims to provide evidence for the potential benefits of exercise in enhancing brain connectivity and physical fitness in SVD patients, potentially informing future treatment guidelines and preventive strategies for this population.
21 studies on the registry are indexed under Stroke, Lacunar; 9 are open to participants now.
This study's planned enrollment of 60 is close to the median of 60 across 15 interventional studies indexed under Stroke, Lacunar.
Browse Stroke, Lacunar studies →University of L'Aquila is the lead sponsor of 46 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will be allocated to physical activity intervention during the 24 weeks of follow-up.
Behavioral: Physical activity
Participants will not be randomized to physical activity intervention during the first 24 weeks of follow-up. They will be randomized after the 24 weeks of follow-up.
Behavioral: Physical activity
Randomization to a 24-week physical exercise program
Also known as: Physical activity (delayed)
Change in Senior Fitness Test score
Change in the Senior Fitness score from before to after the 24-week physical exercise intervention
Time frame: 24 weeks
Change in International Physical Activity Questionnaire (IPAQ) score
Change in International Physical Activity Questionnaire (IPAQ) score from before to after the 24-week physical exercise intervention
Time frame: 24 weeks
Change in Body Mass Index
Change in Body Mass Index score from before to after the 24-week physical exercise intervention
Time frame: 24 weeks
Change in blood pressure
Change in blood pressure from before to after the 24-week physical exercise intervention
Time frame: 24 weeks
Change in heart rate
Change in heart rate from before to after the 24-week physical exercise intervention
Time frame: 24 weeks
Change in brain functional connectivity
Overall brain functional connectivity in the resting state assessed via high-density electroencephalogram
Time frame: 24 weeks
Plan to share: No — IPD will be available from the central contact person upon reasonable request.
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for Dec 2026, 19 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of L'Aquila